Amendment #001-Mammalian Bioreactor Control System Brand Name or Equal

Subject: Amendment #001-Mammalian Bioreactor Control System Brand Name or Equal
Solicitation Number: RFQ-NIAID-23-2177803
Notice Type: SOLICIT
NAICS: 334516
Notice Published: 09-21-23
Response Due: 09-25-23

Agency: Department of Health and Human Services
Contact: Kelly Dempsey This email address is being protected from spambots. You need JavaScript enabled to view it.
Office Address: BETHESDA, MD 20892

Related Notices:
        09-20-23 SOLICIT

        09-26-23 SOLICIT

Click for official SAM (FBO) notice, additional information, and accompanying attachments

Amendment #001, dated September 21, 2023. See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions, including the due date of quotes, remain the same. This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ). The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC). The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.